Source: Annual Congress 2006 - Airway regulation, provocation and monitoring - III
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. H. Chen, W. Z. Yao, Y. L. Ding, B. Geng, M. Lu, M. W. Zhao, C. S. Tang (Beijing, China). Effect of theophylline on endogenous hydrogen sulfide in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 3891

Member's Comments

No comment yet.

Related content which might interest you: The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014 Changes of endogenous hydrogen sulfide in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 Variation of exhaled hydrogen peroxide in stable COPD patients and matched healthy persons over time Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Effects of low dose inhaled carbon monoxide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Evaluation of hydrogen perioxide in breath condensate in children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Endogenous hydrogen sulfide (H2S) in serum and sputum as novel biomarker of asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008 Exhaled hydrogen peroxide in patients with stable chronic obstructive pulmonary disease: effect of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 The effect of oral corticosteroid on spirometeric parameters in COPD patients induced by mustard gas Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Vasorelaxant effect of hydrogen sulfide (H2S) in human isolated pulmonary vessels Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005